Equifax Inc.
NYSEWhy this matters: Equifax is trading at $170.45, down 20% YTD and 24.7% below the analyst consensus target. Since the Q2 earnings beat on July 15, bears have rebuilt aggressively. Three separate signals now confirm the same direction. Short interest hit 5.3% of free float on July 22. That is up roughly 17% from the ~4.5% level noted before the Q2…
EFX cost to borrow doubled to 0.44% over one week, though remains low in absolute terms. Short interest at 4.6% of float shows modest activity, with availability at 1,442% indicating abundant shares to borrow relative to short positions.
Why this matters: Equifax is trading at $170.45, down 20% YTD and 24.7% below the analyst consensus target. Since the Q2 earnings beat on July 15, bears have rebuilt aggressively. Three separate signals now confirm the…
Equifax reported earnings on July 21 and the Street's response was swift and unified — a wave of target cuts from across the analyst community, landing on a stock that had already given back most of its post-Q2…
Snapshot as of 6 Aug 2026
Equifax heads into its July 21 Q3 preview print with a notably changed setup from the last two previews: short interest has reversed sharply higher, and options traders have grown more defensive than they have been in…
Equifax reports Q2 results on July 15 with the short base continuing to unwind, the borrow market increasingly uncrowded, and a Street consensus that is broadly constructive — but the stock has given back ground since…
Equifax enters its July 15 earnings report with a clean 10% weekly gain behind it, a shrinking short base, and a Street consensus that remains broadly constructive — yet options traders have quietly shifted toward…
Equifax enters the back half of May with its stock down 18% on the month, CEO-level selling on the books, and short interest quietly building — a combination that puts the bears in a stronger position than they have…
Equifax reports first-quarter results on May 7 with short sellers building positions, analysts trimming targets, and the CEO selling stock within the last two weeks — a cluster of cautious signals heading into the…
Equifax enters May with a bruising April earnings reaction still fresh — and its CEO selling into the weakness. Mark Begor filed four sell transactions on April 24, three days after the stock dropped nearly 10% on Q1…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for EFX — free to start on ORTEX.
Sign up for free →Open EFX on ORTEX